FinTrack: August 2018

FinTrack: August 2018

Summary

Every month, FinTrack will showcase the latest innovations from financial providers around the world. Each innovation is assessed and rated on key criteria, providing you with valuable insight.

The provision of financial services is constantly evolving, with new technology having a particularly significant impact. Innovations such as digital delivery, AI, biometrics, and robo-advice are enabling providers around the world to offer new and improved services to customers that will improve the way they manage their finances. The growing availability of these technologies is also making it easier than ever for new entrants to develop their own propositions and challenge the established providers.

Scope

- Revolut launches new premium card account.
- Pineapple is set to revolutionize P2P insurance.
- Fidelity inaugurates the era of 0% index funds.

Reasons to buy

- Keep up to date with the latest innovations from your competitors.
- Develop cutting-edge product and channel strategies.
- Identify the latest trends in the delivery of financial services.

Consumer Payments
Go-Pay QR payments expand to roadside kiosks in Jakarta
Revolut launches new premium card account

General Insurance
Indie is a life insurer that also creates wealth
FloodFlash offers at-risk customers seamless claims payouts
Pineapple is set to revolutionize P2P insurance

Wealth Management
Fidelity inaugurates the era of 0% index funds
Balance Impact is a 100% online ethical investment service
Praemium adds Macrovue thematic portfolios to its platform

Appendix

Siemens AG (SIE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution;

USD 250 View Report

Oxurion NV (THR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oxurion NV(Oxurion) formerly known as ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The companys ocriplasmin, a recombinant derivative of the plasmin protein, is

USD 250 View Report

Siemens AG (SIE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution;

USD 250 View Report

Oxurion NV (THR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oxurion NV(Oxurion) formerly known as ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The companys ocriplasmin, a recombinant derivative of the plasmin protein, is

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available